Increased prevalence of diabetic complications in Japanese patients with type 1 diabetes and nonalcoholic fatty liver disease

被引:8
作者
Yoneda C. [1 ]
Ogino J. [1 ]
Matsuura H. [1 ]
Haruki T. [1 ]
Suzuki Y. [2 ]
Hashimoto N. [1 ]
机构
[1] Department of Diabetes, Endocrine and Metabolic Diseases, Yachiyo Medical Center, Tokyo Women's Medical University, Yachiyo, 276-8524
[2] Department of Diabetes and Metabolic Diseases, Asahi General Hospital, Asahi, Chiba, 289-2511
关键词
Diabetic complication; Macroangiopathy; Nonalcoholic fatty liver disease; Type; 1; diabetes;
D O I
10.1007/s13340-011-0061-8
中图分类号
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is associated with insulin resistance, metabolic syndrome and cardiovascular disease. The purpose of this study was to evaluate the phenotype of Japanese type 1 diabetes with NAFLD. The study population consisted of patients with type 1 diabetes with (n = 25) and without (n = 119) NAFLD who underwent an examination with hepatic ultrasonography. The duration of diabetes, HbA1c, body mass index, basal and bolus insulin doses, urinary albumin excretion, prevalence of carotid artery plaques, and incidence of retinopathy in patients with NAFLD were all significantly higher than in those without NAFLD. Dyslipidemia and hypertension also occurred more frequently in the NAFLD group. Logistic analysis showed that age (P < 0. 05), gender (P < 0. 05), duration of diabetes (P < 0. 05), dyslipidemia (P < 0. 05), and the presence of NAFLD (P < 0. 05) were independent risk factors for the presence of carotid artery plaque. Multiple regression analysis showed that the rate of urinary albumin excretion was significantly associated with age (P < 0. 01), systolic blood pressure (P < 0. 05), and the presence of NAFLD (P < 0. 01). Our results suggest that the presence of NAFLD in type 1 diabetes may be strongly associated with the progression of diabetic nephropathy and macroangiopathy. © 2011 The Japan Diabetes Society.
引用
收藏
页码:37 / 41
页数:4
相关论文
共 50 条
[11]   Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease [J].
Raschi, Emanuel ;
Mazzotti, Arianna ;
Poluzzi, Elisabetta ;
De Ponti, Fabrizio ;
Marchesini, Giulio .
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (17) :1903-1914
[12]   Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight/obese youth with polycystic ovary syndrome [J].
Patel-Sanchez, Namrata ;
Perito, Emily ;
Tsai, Patrika ;
Raymond-Flesch, Marissa ;
Lodish, Maya ;
Sarkar, Monika .
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2023, 36 (05) :441-446
[13]   Nonalcoholic fatty liver disease in type 2 diabetes mellitus [J].
Cusi, Kenneth .
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2009, 16 (02) :141-149
[14]   Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes [J].
Lv, Wen-Shan ;
Sun, Rui-Xia ;
Gao, Yan-Yan ;
Wen, Jun-Ping ;
Pan, Rong-Fang ;
Li, Li ;
Wang, Jing ;
Xian, Yu-Xin ;
Cao, Cai-Xia ;
Zheng, Ming .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (20) :3134-3142
[15]   Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes [J].
Wen-Shan Lv ;
Rui-Xia Sun ;
Yan-Yan Gao ;
Jun-Ping Wen ;
Rong-Fang Pan ;
Li Li ;
Jing Wang ;
Yu-Xin Xian ;
Cai-Xia Cao ;
Ming Zheng .
World Journal of Gastroenterology, 2013, (20) :3134-3142
[16]   The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease [J].
Ng, Cheng Han ;
Chan, Kai En ;
Chin, Yip Han ;
Zeng, Rebecca Wenling ;
Tsai, Pei Chen ;
Lim, Wen Hui ;
Tan, Darren Jun Hao ;
Khoo, Chin Meng ;
Goh, Lay Hoon ;
Ling, Zheng Jye ;
Kulkarni, Anand ;
Mak, Lung-Yi Loey ;
Huang, Daniel Q. ;
Chan, Mark ;
Chew, Nicholas W. S. ;
Siddiqui, Mohammad Shadab ;
Sanyal, Arun J. ;
Muthiah, Mark .
CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (03) :565-574
[17]   Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic fatty liver disease [J].
Wang, Chao-Hung ;
Leung, Ching-Hsiang ;
Liu, Sung-Chen ;
Chung, Cheng-Ho .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2006, 105 (09) :743-752
[18]   Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes [J].
Targher, Giovanni ;
Valbusa, Filippo ;
Bonapace, Stafano ;
Bertolini, Lorenzo ;
Zenari, Luciano ;
Pichiri, Isabella ;
Mantovani, Alessandro ;
Zoppini, Giacomo ;
Bonora, Enzo ;
Barbieri, Enrico ;
Byrne, Christopher D. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (06) :663-669
[19]   Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease [J].
Mantovani, Alessandro ;
Pernigo, Matteo ;
Bergamini, Corinna ;
Bonapace, Stefano ;
Lipari, Paola ;
Valbusa, Filippo ;
Bertolini, Lorenzo ;
Zenari, Luciano ;
Pichiri, Isabella ;
Dauriz, Marco ;
Zoppini, Giacomo ;
Barbieri, Enrico ;
Byrne, Christopher D. ;
Bonora, Enzo ;
Targher, Giovanni .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (08) :879-887
[20]   Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients [J].
Targher, G. ;
Bertolini, L. ;
Chonchol, M. ;
Rodella, S. ;
Zoppini, G. ;
Lippi, G. ;
Zenari, L. ;
Bonora, E. .
DIABETOLOGIA, 2010, 53 (07) :1341-1348